StockpollyBeta
Get App
Popularity #1,076
HELP · NASDAQ · Medical - Pharmaceuticals

Helus Pharma (HELP)

Develops investigational serotonergic therapies for depression and generalized anxiety disorder.

$12.85
vs last close−0.86 (−6.25%)

In millions of USD, except per-share figures

In millionsQ2 FY24Sep 2023Q3 FY24Dec 2023Q4 FY24Mar 2024Q1 FY25Jun 2024Q2 FY25Sep 2024Q3 FY25Dec 2024Q4 FY25Mar 2025Q1 FY26Jun 2025Q2 FY26Sep 2025Q3 FY26Dec 2025Q4 FY26Mar 2026Q1 FY27Jun 2026
Cost of revenue000000000000
Gross profit000000000000
142725155832332540414848
Research & development78126919191526242930
7191394913141014171918
Selling & marketing002011310150
General & administrative71912948121191416140
Operating income−14−27−25−15−58−32−33−25−40−41−48−48
2−34412130−7−111
Interest income000232111221
Income before tax−12−30−21−11−57−11−31−25−47−43−47−47
Net income from continuing operations−12−30−21−11−57−11−31−25−47−43−47−47
Net income−12−30−21−11−57−11−31−25−47−43−47−47
EPS, basic−$1.93−$3.45−$1.07−$0.55−$2.84−$0.54−$1.46−$1.10−$1.94−$1.76−$0.92−$0.89
EPS, diluted−$1.93−$3.45−$1.07−$0.55−$2.84−$0.54−$1.46−$1.10−$1.94−$1.76−$0.92−$0.89
Weighted average shares, basic6920202020212224245052
Weighted average shares, diluted6920202020212224245052
EBITDA−14−27−25−15−58−32−33−25−40−41−48−48
Depreciation & amortization000000000000
EBIT−14−27−25−15−58−32−33−25−40−41−48−48